Thinh Pham is an accomplished professional in the field of biomarker sciences and diagnostics, currently serving as Director of Biomarker Sciences - IVD at Gilead Sciences since September 2022. Pham leads diagnostic development for significant oncology programs, including Trodelvy, domvanalimab, and zimberelimab. Prior experience includes various leadership roles at Genentech from August 1999 to September 2022, where responsibilities ranged from CDx Cancer Immunotherapy Franchise Lead to Senior Research Associate. Additionally, Thinh Pham held the position of Senior Research Scientist specializing in clinical histochemistry at Bristol-Myers Squibb from February 2016 to September 2017. Educational background includes a Bachelor of Science degree in Genetics from the University of California, Davis, earned in January 1999.
This person is not in the org chart
This person is not in any teams
This person is not in any offices